| Model Number |
11500A |
| Medical Device Problem Code |
Device Stenosis (4066)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
| Date of Event |
12/09/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that a patient with a 21mm 11500a aortic valve underwent a valve-in-valve procedure after an implant duration of 4 years, 6 months due to stenosis.The tavr was successfully performed with a 23mm 9755rsl valve.The patient was taken to recovery with stable vital signs post procedure.
|
| |
|
Additional Manufacturer Narrative
|
|
H11: additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
| |
|
Additional Manufacturer Narrative
|
|
H11: additional manufacturer narrative: updated: g3, g6, h2, h6: (type of investigation, investigation findings, investigation conclusions).Stenosis is a common manifestation of bioprosthetic valve and valved conduit dysfunction and has many potential root causes, including structural valve deterioration (svd), non-structural valve dysfunction (nsvd), endocarditis and/or thrombosis.Bioprosthetic device stenosis is typically related to patient and/or procedural factors and is not typically an indication of a device malfunction related to a manufacturing deficiency.There is no evidence to suggest a manufacturing defect caused or contributed to the reported event.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.
|
| |
|
Search Alerts/Recalls
|